Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome (Q39031676)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 2005

Language	Label	Description	Also known as
English	Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome	scientific article published on July 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

based on heuristic

inferred from title

Sharon R. Lewin

6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jasminka Sterjovski

2

0 references

1

0 references

Anthony L. Cunningham

9

0 references

Steven L Wesselingh

8

object named as

Steven L Wesselingh

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Melissa Churchill

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Philip Ellery

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Najla Nasr

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Suzanne M Crowe

7

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Paul R Gorry

10

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

language of work or name

0 references

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

337

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

384-398

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

2 references

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Opposite Effects of IL-10 on the Ability of Dendritic Cells and Macrophages to Replicate Primary CXCR4-Dependent HIV-1 Strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

In vitro replication kinetics of human immunodeficiency virus type 1 (HIV-1) variants in relation to virus load in long-term survivors of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and beta-chemokine production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Longitudinal Analysis ofnef/Long Terminal Repeat–Deleted HIV‐1 in Blood and Cerebrospinal Fluid of a Long‐Term Survivor Who Developed HIV‐Associated Dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Chemokine receptors and the clinical course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Chemokine receptor regulation and HIV type 1 tropism in monocyte-macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

HIV-1 tropism and co-receptor use

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Analysis of cellular factors influencing the replication of human immunodeficiency virus type I in human macrophages derived from blood of different healthy donors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Envelope glycoprotein determinants of increased fusogenicity in a pathogenic simian-human immunodeficiency virus (SHIV-KB9) passaged in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Infection of human tonsil histocultures: a model for HIV pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Restricted HIV-1 infection of human astrocytes: potential role of nef in the regulation of virus replication.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Persistence of dual-tropic HIV-1 in an individual homozygous for the CCR5 Delta 32 allele.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Pathogenesis of macrophage tropic HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

The amino terminus of human CCR5 is required for its function as a receptor for diverse human and simian immunodeficiency virus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Relationship between productive HIV-1 infection of macrophages and CCR5 utilization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Mt-2 Cell Tropism Of Human Immunodeficiency Virus Type 1 Isolates As A Marker For Response To Treatment And Development Of Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Decreasing sensitivity to RANTES (regulated on activation, normally T cell-expressed and -secreted) neutralization of CC chemokine receptor 5-using, non-syncytium-inducing virus variants in the course of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Increased In Vitro Cytopathicity of CC Chemokine Receptor 5–Restricted Human Immunodeficiency Virus Type 1 Primary Isolates Correlates with a Progressive Clinical Course of Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Apoptosis induced in synchronized human immunodeficiency virus type 1-infected primary peripheral blood mononuclear cells is detected after the peak of CD4+ T-lymphocyte loss and is dependent on the tropism of the gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Surface CD4 Is Critical to in Vitro HIV Infection of Human Alveolar Macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

A human immunodeficiency virus type 1 isolate from an infected person homozygous for CCR5Delta32 exhibits dual tropism by infecting macrophages and MT2 cells via CXCR4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Restriction of HIV Type 1 Infection in Macrophages Heterozygous for a Deletion in the CC-Chemokine Receptor 5 Gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enh

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Concordant utilization of macrophage entry coreceptors by related variants within an HIV type 1 primary isolate viral swarm

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential tropism and chemokine receptor expression of human immunodeficiency virus type 1 in neonatal monocytes, monocyte-derived macrophages, and placental macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent CCR5 utilization and enhanced macrophage tropism by primary blood human immunodeficiency virus type 1 isolates from advanced stages of disease and comparison to tissue-derived isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.04.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2005.04.034

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39031676&oldid=1803349533"